πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 15 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12383516

Albuterol aerosol suspension formulation for oral inhalation with high amount of green pro

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11357782

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11253506

Compounds, compositions and methods for preventing and/or treating chlorine inhalation tox

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10799511

Methods for reducing or ameliorating mortality and/or morbidity due to chlorine inhalation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10716793

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue Jul 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10695308

Inhalation formulations of treprostinil

United Therapeutics Corporation Β· Granted Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10376525

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10111957

Inhalation compositions comprising glucose anhydrous

ARVEN ILAC SANAYI VE TICARET A.S. Β· Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10105316

Inhalation compositions comprising muscarinic receptor antagonist

ARVEN ILAC SANAYI VE TICARET A.S. Β· Granted Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10076505

Inhalation formulations of Treprostinil

United Therapeutics Corporation Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9358240

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9339507

Treprostinil administration by inhalation

United Therapeutics Corporation Β· Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. Β· Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 6756033

Method for delivering benzindene prostaglandins by inhalation

United Therapeutics Corporation Β· Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6521212

Method for treating peripheral vascular disease by administering benzindene prostaglandins

United Therapeutics Corporation Β· Granted Tue Feb 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired